Valuation: Rohto Pharmaceutical Co.,Ltd.

Market Cap 648B 4.07B 3.49B 3.27B 2.99B 5.61B 390B 5.68B 38.58B 15.05B 196B 15.3B 14.97B P/E 2027 *
18.5x
P/E 2028 * 17.3x
Enterprise Value 586B 3.69B 3.16B 2.96B 2.71B 5.08B 353B 5.15B 34.93B 13.62B 177B 13.85B 13.55B EV / Sales 2027 *
1.58x
EV / Sales 2028 * 1.47x
Free-Float
84.69%
Yield 2027 *
1.75%
Yield 2028 * 1.8%
1 day-0.02%
1 week+1.81%
Current month+20.01%
1 month+17.72%
3 months+13.93%
6 months+20.59%
Current year+9.08%
1 week 2,725.5
Extreme 2725.5
2,901.5
1 month 2,285
Extreme 2285
2,918.5
Current year 2,218.5
Extreme 2218.5
2,918.5
1 year 2,218.5
Extreme 2218.5
2,918.5
3 years 1,964.5
Extreme 1964.5
4,117
5 years 1,515
Extreme 1515
4,117
10 years 771
Extreme 771
4,117
Manager TitleAgeSince
Chief Executive Officer 70 2019-05-31
President 64 2025-06-25
Director of Finance/CFO 62 2022-02-28
Director TitleAgeSince
Chairman 70 2009-05-31
Director/Board Member 70 2010-05-31
Director/Board Member 62 2011-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%+1.81%+13.82%-21.21% 4.07B
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +1.16%+4.66%+29.56%+45.76% 380.39B
Weighted average by Cap. +1.14%+5.09%+44.27%+72.45%

Financials

2027 *2028 *
Net sales 371B 2.33B 2B 1.87B 1.71B 3.21B 223B 3.26B 22.1B 8.62B 112B 8.76B 8.57B 385B 2.42B 2.08B 1.94B 1.78B 3.34B 232B 3.38B 22.95B 8.95B 116B 9.1B 8.9B
Net income 35.02B 220M 189M 177M 162M 303M 21.08B 307M 2.09B 813M 10.59B 827M 809M 37.47B 236M 202M 189M 173M 325M 22.55B 329M 2.23B 870M 11.33B 885M 866M
Net Debt -61.32B -386M -330M -309M -283M -531M -36.91B -538M -3.65B -1.42B -18.54B -1.45B -1.42B -80.92B -509M -436M -408M -373M -701M -48.7B -710M -4.82B -1.88B -24.47B -1.91B -1.87B
Logo Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
Employees
9,292
Date Price Change Volume
26-08-21 JP¥2,866.50 -0.02% 1,044,000
26-08-20 JP¥2,867.00 +2.21% 1,096,500
26-08-19 JP¥2,805.00 +1.25% 1,014,100
26-08-18 JP¥2,770.50 +0.75% 672,700
26-08-17 JP¥2,750.00 -2.33% 779,900
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
2,866.50JPY
Average target price
2,975.45JPY
Spread / Average Target
+3.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4527 Stock